Hormone replacement therapy in relation to survival in women diagnosed with colon cancer

Margaret T. Mandelson, Diana L Miglioretti, Polly A. Newcomb, Robert Harrison, John D. Potter

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Introduction: Colorectal cancer is the second leading cause of cancer death among US men and women. A number of studies report that hormone replacement therapy (HRT) reduces the risk of colorectal cancer, but fewer studies have examined the relation between HRT use and survival after diagnosis and none examined this relation by anatomic location of the primary colon tumor. Methods: Data from a cohort of 699 women 50-79 years of age diagnosed with colon cancer between 1980 and 1998 in a large Health Maintenance Organization based in Seattle, Washington were analyzed to examine the relation between HRT use prior to diagnosis and survival. Use of HRT was ascertained from a computerized pharmacy database. Results: HRT use was associated with a 41% reduction in risk of death after adjustment for age, stage, and diagnosis year (p = 0.037). The association between HRT use and colon cancer survival was strongest among women with cancer in the distal colon (hazard rate ratio 0.33, 95% confidence interval, 95% CI: 0.13-0.83), while little or no association between HRT use and survival was observed among women with proximal tumors (HRR 0.78, 95% CI: 0.42-1.44). Conclusions: These findings suggest that HRT use is associated with improved survival from colon cancer. Future observational and laboratory studies should shed light on how hormones may be related to reduced incidence and improved prognosis.

Original languageEnglish (US)
Pages (from-to)979-984
Number of pages6
JournalCancer Causes and Control
Volume14
Issue number10
DOIs
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Hormone Replacement Therapy
Colonic Neoplasms
Survival
Colorectal Neoplasms
Neoplasms
Colon
Health Maintenance Organizations
Risk Reduction Behavior
Observational Studies
Cause of Death
Databases
Hormones
Confidence Intervals
Incidence

Keywords

  • Colon cancer
  • Disease stage
  • Hormone replacement therapy
  • Prognosis
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Epidemiology
  • Cancer Research

Cite this

Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. / Mandelson, Margaret T.; Miglioretti, Diana L; Newcomb, Polly A.; Harrison, Robert; Potter, John D.

In: Cancer Causes and Control, Vol. 14, No. 10, 12.2003, p. 979-984.

Research output: Contribution to journalArticle

Mandelson, Margaret T. ; Miglioretti, Diana L ; Newcomb, Polly A. ; Harrison, Robert ; Potter, John D. / Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. In: Cancer Causes and Control. 2003 ; Vol. 14, No. 10. pp. 979-984.
@article{8973ac6a537c490dad99cad4af0d4141,
title = "Hormone replacement therapy in relation to survival in women diagnosed with colon cancer",
abstract = "Introduction: Colorectal cancer is the second leading cause of cancer death among US men and women. A number of studies report that hormone replacement therapy (HRT) reduces the risk of colorectal cancer, but fewer studies have examined the relation between HRT use and survival after diagnosis and none examined this relation by anatomic location of the primary colon tumor. Methods: Data from a cohort of 699 women 50-79 years of age diagnosed with colon cancer between 1980 and 1998 in a large Health Maintenance Organization based in Seattle, Washington were analyzed to examine the relation between HRT use prior to diagnosis and survival. Use of HRT was ascertained from a computerized pharmacy database. Results: HRT use was associated with a 41{\%} reduction in risk of death after adjustment for age, stage, and diagnosis year (p = 0.037). The association between HRT use and colon cancer survival was strongest among women with cancer in the distal colon (hazard rate ratio 0.33, 95{\%} confidence interval, 95{\%} CI: 0.13-0.83), while little or no association between HRT use and survival was observed among women with proximal tumors (HRR 0.78, 95{\%} CI: 0.42-1.44). Conclusions: These findings suggest that HRT use is associated with improved survival from colon cancer. Future observational and laboratory studies should shed light on how hormones may be related to reduced incidence and improved prognosis.",
keywords = "Colon cancer, Disease stage, Hormone replacement therapy, Prognosis, Survival",
author = "Mandelson, {Margaret T.} and Miglioretti, {Diana L} and Newcomb, {Polly A.} and Robert Harrison and Potter, {John D.}",
year = "2003",
month = "12",
doi = "10.1023/B:CACO.0000007970.04094.76",
language = "English (US)",
volume = "14",
pages = "979--984",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "10",

}

TY - JOUR

T1 - Hormone replacement therapy in relation to survival in women diagnosed with colon cancer

AU - Mandelson, Margaret T.

AU - Miglioretti, Diana L

AU - Newcomb, Polly A.

AU - Harrison, Robert

AU - Potter, John D.

PY - 2003/12

Y1 - 2003/12

N2 - Introduction: Colorectal cancer is the second leading cause of cancer death among US men and women. A number of studies report that hormone replacement therapy (HRT) reduces the risk of colorectal cancer, but fewer studies have examined the relation between HRT use and survival after diagnosis and none examined this relation by anatomic location of the primary colon tumor. Methods: Data from a cohort of 699 women 50-79 years of age diagnosed with colon cancer between 1980 and 1998 in a large Health Maintenance Organization based in Seattle, Washington were analyzed to examine the relation between HRT use prior to diagnosis and survival. Use of HRT was ascertained from a computerized pharmacy database. Results: HRT use was associated with a 41% reduction in risk of death after adjustment for age, stage, and diagnosis year (p = 0.037). The association between HRT use and colon cancer survival was strongest among women with cancer in the distal colon (hazard rate ratio 0.33, 95% confidence interval, 95% CI: 0.13-0.83), while little or no association between HRT use and survival was observed among women with proximal tumors (HRR 0.78, 95% CI: 0.42-1.44). Conclusions: These findings suggest that HRT use is associated with improved survival from colon cancer. Future observational and laboratory studies should shed light on how hormones may be related to reduced incidence and improved prognosis.

AB - Introduction: Colorectal cancer is the second leading cause of cancer death among US men and women. A number of studies report that hormone replacement therapy (HRT) reduces the risk of colorectal cancer, but fewer studies have examined the relation between HRT use and survival after diagnosis and none examined this relation by anatomic location of the primary colon tumor. Methods: Data from a cohort of 699 women 50-79 years of age diagnosed with colon cancer between 1980 and 1998 in a large Health Maintenance Organization based in Seattle, Washington were analyzed to examine the relation between HRT use prior to diagnosis and survival. Use of HRT was ascertained from a computerized pharmacy database. Results: HRT use was associated with a 41% reduction in risk of death after adjustment for age, stage, and diagnosis year (p = 0.037). The association between HRT use and colon cancer survival was strongest among women with cancer in the distal colon (hazard rate ratio 0.33, 95% confidence interval, 95% CI: 0.13-0.83), while little or no association between HRT use and survival was observed among women with proximal tumors (HRR 0.78, 95% CI: 0.42-1.44). Conclusions: These findings suggest that HRT use is associated with improved survival from colon cancer. Future observational and laboratory studies should shed light on how hormones may be related to reduced incidence and improved prognosis.

KW - Colon cancer

KW - Disease stage

KW - Hormone replacement therapy

KW - Prognosis

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0347720639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347720639&partnerID=8YFLogxK

U2 - 10.1023/B:CACO.0000007970.04094.76

DO - 10.1023/B:CACO.0000007970.04094.76

M3 - Article

C2 - 14750537

AN - SCOPUS:0347720639

VL - 14

SP - 979

EP - 984

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 10

ER -